Skip to main content
Year archive

CG Invites Co., Ltd. — 2023 filings

All 94 regulatory filings released by CG Invites Co., Ltd. (083790) in 2023, sourced directly from the official regulator.

94 Filings
2023 Period
2023 filings (94)
Filing Released Lang
타법인주식및출자증권취득결정
M&A Activity
2023-12-28 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares
2023-12-27 Korean
[기재정정]주요사항보고서(자기주식처분결정)
Transaction in Own Shares
2023-12-27 Korean
자기주식처분결과보고서
Transaction in Own Shares
2023-12-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-12 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-11-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-06 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-06 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-06 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-06 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-03 Korean
타법인주식및출자증권취득결정(자율공시)
M&A Activity
2023-10-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-09-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-09-25 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-09-20 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-09-18 Korean
[기재정정]증권발행결과(자율공시)(제3자배정(상환전환우선주)-신주발행무효)
Share Issue/Capital Change
2023-09-18 Korean
기타주요경영사항(신주발행무효)
Share Issue/Capital Change
2023-09-18 Korean
소송등의판결ㆍ결정(신주발행무효)
Legal Proceedings Report
2023-08-28 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-17 Korean
파생상품거래손실발생
Earnings Release H1 2023
2023-08-17 Korean
소속부변경
Regulatory Filings
2023-08-17 Korean
기타경영사항(자율공시)(반기보고서 미제출 사유)
Report Publication Announcement
2023-08-14 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-08-11 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update
2023-07-25 Korean
대표이사변경
Board/Management Information
2023-07-18 Korean
소송등의판결ㆍ결정(주주총회소집허가-취하)
Legal Proceedings Report
2023-07-18 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-07-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-07-06 Korean
[기재정정]사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-06-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-06-29 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-06-29 Korean
상호변경안내
Regulatory Filings
2023-06-29 Korean
기타시장안내(최대주주의의무보유관련)
Major Shareholding Notification
2023-06-22 Korean
소송등의제기ㆍ신청(경영권분쟁소송)(주주총회소집허가)
Legal Proceedings Report
2023-06-21 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-06-19 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-06-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-06-14 Korean
[기재정정]주주총회소집결의
AGM Information
2023-06-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-06-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2023-06-12 Korean
기타경영사항(자율공시)(특허권 취득)
Regulatory Filings
2023-06-08 Korean
기타시장안내(최대주주의의무보유관련)
Major Shareholding Notification
2023-06-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-06-05 Korean
증권발행결과(자율공시)(제3자배정 유상증자-보통주 및 상환전환우선주)
Share Issue/Capital Change
2023-06-02 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change
2023-06-02 Korean
최대주주변경
Major Shareholding Notification
2023-06-02 Korean
기타시장안내(최대주주의 의무보유 대상 확인 관련)
Major Shareholding Notification
2023-06-02 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-05-30 Korean
주요사항보고서(소송등의제기)
Legal Proceedings Report
2023-05-26 Korean
주요사항보고서(유상증자결정)
Capital/Financing Update
2023-05-22 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-05-22 Korean
주주총회소집결의(임시주주총회)
AGM Information
2023-05-19 Korean
주주명부폐쇄기간또는기준일설정(임시주주총회)
Regulatory Filings
2023-05-19 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-05-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-05-11 Korean
[기재정정]신규시설투자등
Regulatory Filings
2023-04-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-04-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-04-20 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-04-13 Korean
대표이사변경
Board/Management Information
2023-04-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-04-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-04-05 Korean
최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification
2023-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-29 Korean
[기재정정]주주총회소집결의
AGM Information
2023-03-29 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-29 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-29 Korean
소송등의판결ㆍ결정(의결권행사금지가처분)
Legal Proceedings Report
2023-03-29 Korean
[기재정정]주요사항보고서(소송등의제기)
Legal Proceedings Report
2023-03-28 Korean
주요사항보고서(소송등의제기)
Legal Proceedings Report
2023-03-27 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-21 Korean
주주총회소집결의
AGM Information
2023-03-14 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-28 Korean
[기재정정]투자판단관련주요경영사항(진행성 혹은 전이성 비편평 비소세포폐암 환자의 1차 치료제로서 항 PD-1항체인 camrelizumab (SHR-1210)과 Pemetrexed, Carboplatin과의 병용요법에 대한 공개, 다기관 임상시험 계획(IND)승인)
Legal Proceedings Report
2023-02-21 Korean
투자판단관련주요경영사항(진행성 혹은 전이성 비편평 비소세포폐암 환자의 1차 치료제로서 항 PD-1항체인 camrelizumab (SHR-1210)과 Pemetrexed, Carboplatin과의 병용요법에 대한 공개, 다기관 임상시험 계획(IND)승인)
Regulatory Filings
2023-02-20 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제12회차)
Capital/Financing Update
2023-02-07 Korean
[기재정정]타법인주식및출자증권취득결정
M&A Activity
2023-01-06 Korean
[기재정정]주주총회소집결의
AGM Information
2023-01-02 Korean
[기재정정]주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2023-01-02 Korean